A Phase 1, double-blind, randomized, placebo controlled, Parallel study to assess the safety, tolerability and pharmacokinetics of single and multiple doses of MKP 10241 Suspension administered orally in healthy adult, human, male subjects.
100 项与 MKP-10241 相关的专利(医药)